Lipoprotein (a) and Stroke: An Overview

No abstract is available for this paper.

• Publication year

  2010

• Venue

  The Open Clinical Chemistry Journal

• Publication date

  2010-04-08

• Fields of study

  Medicine

• Identifiers
  DOI 10.2174/1874241601003010038
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar

• No claims are published for this paper.

• No concepts are published for this paper.

• Sentinel Surveillance of Influenza-Like-Illness in Two Cities of the Tropical Country of Ecuador: 2006–2010

  2011cited by this paper
• Homocysteine and lipoprotein (a) correlation in ischemic stroke patients.

  2009cited by this paper
• Genetically elevated lipoprotein(a) and increased risk of myocardial infarction.

  2009cited by this paper
• A NEW SERUM TYPE SYSTEM IN MAN--THE LP SYSTEM.

  2009cited by this paper
• Lipoprotein a: where are we now?

  2009influential reference
• Lipoprotein(a) concentration and the risk of coronary heart disease, stroke, and nonvascular mortality.

  2009cited by this paper
• Lipoprotein (a) as a risk factor for silent cerebral infarction in hemodialysis patients.

  2008cited by this paper
• Niacin and lipoprotein(a): facts, uncertainties, and clinical considerations.

  2008cited by this paper
• Antisense Oligonucleotide Directed to Human Apolipoprotein B-100 Reduces Lipoprotein(a) Levels and Oxidized Phospholipids on Human Apolipoprotein B-100 Particles in Lipoprotein(a) Transgenic Mice

  2008cited by this paper
• Lipoprotein(a) levels and risk of future coronary heart disease: large-scale prospective data.

  2008cited by this paper
• Lipoprotein(a) Is Associated Differentially With Carotid Stenosis, Occlusion, and Total Plaque Area

  2008cited by this paper
• [Lipoprotein (a) and stroke].

  2008cited by this paper
• Treatment of hyperlipidaemia with fenofibrate and related fibrates.

  2008cited by this paper
• Elevated lipoprotein (a) and apolipoprotein B to AI ratio in South Asian patients with ischaemic stroke *

  2007cited by this paper
• Effect of aspirin on lipoprotein(a) in patients with ischemic stroke.

  2007cited by this paper
• Effects of Renal Replacement Therapy on Plasma Lipoprotein(a) Levels

  2007cited by this paper
• Lipoprotein (a) and risk of ischemic stroke in young adults.

  2007cited by this paper
• Elevated Lipoprotein(a) does not promote early atherosclerotic changes of the carotid arteries in young, healthy adults.

  2007cited by this paper
• Lipoprotein (a) and Stroke: A Meta-Analysis of Observational Studies

  2007cited by this paper
• Plasma lipoprotein(a) indicates risk for 4 distinct forms of vascular disease.

  2007cited by this paper
• Therapeutic potential for thyroid hormone receptor-beta selective agonists for treating obesity, hyperlipidemia and diabetes.

  2007cited by this paper
• Serum lipoprotein(a) levels and apolipoprotein(a) isoform size and risk for first-ever acute ischaemic nonembolic stroke in elderly individuals.

  2006cited by this paper
• Potential New Risk Factors for Ischemic Stroke: What Is Their Potential?

  2006cited by this paper
• Lipoprotein(a) and Incident Ischemic Stroke: The Atherosclerosis Risk in Communities (ARIC) Study

  2006cited by this paper
• Metabolic Risk Factors for Stroke and Transient Ischemic Attacks in Middle-Aged Men: A Community-Based Study With Long-Term Follow-Up

  2006cited by this paper
• Oxidized phospholipids predict the presence and progression of carotid and femoral atherosclerosis and symptomatic cardiovascular disease: five-year prospective results from the Bruneck study.

  2006cited by this paper
• High levels of homocysteine, lipoprotein (a) and plasminogen activator inhibitor-1 are present in patients with abdominal aortic aneurysm

  2005cited by this paper
• Plasma lipoprotein(a) [Lp(a)] concentrations and cardiovascular events in the elderly: evidence from the prospective study of pravastatin in the elderly at risk (PROSPER).

  2005cited by this paper
• Oxidized phospholipids, Lp(a) lipoprotein, and coronary artery disease.

  2005cited by this paper
• Lp(a) lipoprotein, vascular disease, and mortality in the elderly.

  2004cited by this paper
• Lipoprotein(a) and the link between atherosclerosis and thrombosis.

  2004influential reference
• Hypothyroidism and dyslipidemia: Modern concepts and approaches

  2004cited by this paper
• Lipoprotein(a): biology and clinical importance.

  2004cited by this paper
• Serum lipid profile in patients with severe leptospirosis

  2004cited by this paper
• Effect of lipoprotein (a) on platelet activation induced by platelet-activating factor: role of apolipoprotein (a) and endogenous PAF-acetylhydrolase.

  2004cited by this paper
• Lipoprotein (a) downregulates lysosomal acid lipase and induces interleukin-6 in human blood monocytes.

  2003cited by this paper
• Lp(a) lipoprotein--coping with heterogeneity.

  2003cited by this paper
• The Combination of Nebivolol plus Pravastatin is Associated with a More Beneficial Metabolic Profile Compared to that of Atenolol plus Pravastatin in Hypertensive Patients with Dyslipidemia: A Pilot Study

  2003cited by this paper
• Increased plasma levels of lipoprotein(a) and the risk of idiopathic and recurrent venous thromboembolism.

  2003cited by this paper
• Report of the National Heart, Lung, and Blood Institute Workshop on Lipoprotein(a) and Cardiovascular Disease: recent advances and future directions.

  2003cited by this paper
• The effect of L-carnitine on plasma lipoprotein(a) levels in hypercholesterolemic patients with type 2 diabetes mellitus.

  2003cited by this paper
• Lipoprotein(a) and ultrasonographically determined early atherosclerotic changes in the carotid and femoral artery

  2003cited by this paper
• Lipoprotein (a) Levels and Apolipoprotein (a) Isoform Size in Patients with Subclinical Hypothyroidism: Effect of Treatment with Levothyroxine

  2003cited by this paper
• Lp(a) lipoprotein, vascular disease, and mortality in the elderly.

  2003cited by this paper
• Lipoprotein (a) and acute‐phase response in patients with vestibular neuronitis

  2003cited by this paper
• Lipoprotein (a) in patients with aortic aneurysmal disease.

  2002cited by this paper
• Severe hypocholesterolemia with reduced serum lipoprotein(a) in a patient with visceral leishmaniasis.

  2002cited by this paper
• Effect of aspirin treatment on serum concentrations of lipoprotein(a) in patients with atherosclerotic diseases.

  2002cited by this paper
• Alcohol-Extracted, but Not Intact, Dietary Soy Protein Lowers Lipoprotein(a) Markedly

  2002cited by this paper
• Lipoprotein(a) promotes smooth muscle cell proliferation and dedifferentiation in atherosclerotic lesions of human apo(a) transgenic rabbits.

  2002cited by this paper
• Lipoprotein (a) as a predictor of coronary heart disease: the PRIME Study.

  2002influential reference
• Lipoprotein(a) further increases the risk of coronary events in men with high global cardiovascular risk.

  2001cited by this paper
• Lipoprotein (a) and development of intermittent claudication and major cardiovascular events in men and women: the Edinburgh Artery Study.

  2001cited by this paper
• Lipoprotein (a) and the risk of ischemic stroke in young women.

  2000cited by this paper
• Serum lipids in young patients with ischaemic stroke: a case-control study

  2000cited by this paper
• Lipoprotein(a) and Coronary Heart Disease: Meta-Analysis of Prospective Studies

  2000cited by this paper
• Role of lipoprotein(a) and apolipoprotein(a) phenotype in atherogenesis: prospective results from the Bruneck study.

  1999cited by this paper
• Chlamydia pneumoniae antibodies and high lipoprotein(a) levels do not predict ischemic cerebral infarctions. Results from a nested case-control study in Northern Sweden.

  1999cited by this paper
• Lipoprotein(a)-cholesterol and coronary heart disease in the Framingham Heart Study.

  1999influential reference
• Effect of hypertension and its treatment on lipid, lipoprotein(a), fibrinogen, and bilirubin levels in patients referred for dyslipidemia.

  1999cited by this paper
• Expression of adhesion molecules by Lp(a): a potential novel mechanism for its atherogenicity

  1998cited by this paper
• Lipoprotein(a) as a risk factor for ischemic heart disease: metaanalysis of prospective studies.

  1998cited by this paper
• Lp(a) lipoprotein level predicts survival and major coronary events in the Scandinavian Simvastatin Survival Study

  1997influential reference
• Predictive value of electrophoretically detected lipoprotein(a) for coronary heart disease and cerebrovascular disease in a community-based cohort of 9936 men and women.

  1997cited by this paper
• Lipoprotein (a) and its relationship to risk factors and severity of atherosclerotic peripheral vascular disease.

  1997cited by this paper
• Genotype-specific transcriptional regulation of PAI-1 expression by hypertriglyceridemic VLDL and Lp(a) in cultured human endothelial cells.

  1997cited by this paper
• Lipoprotein(a) is a potent chemoattractant for human peripheral monocytes.

  1997cited by this paper
• Lipoprotein(a) in patients with acute cerebral ischemia.

  1996cited by this paper
• New developments in the use of niacin for treatment of hyperlipidemia: new considerations in the use of an old drug.

  1996cited by this paper
• Lipoprotein (a), homocysteine, and hypercoagulable states in young men with premature peripheral atherosclerosis: a prospective, controlled analysis.

  1996cited by this paper
• Effects of lowering elevated LDL cholesterol on the cardiovascular risk of lipoprotein(a).

  1995cited by this paper
• Changes in serum lipoprotein(a) and lipids during treatment of hyperthyroidism.

  1995cited by this paper
• Plasma concentration of lipoprotein(a) and the risk of future stroke.

  1995cited by this paper
• Lipoproteins inhibit the secretion of tissue plasminogen activator from human endothelial cells.

  1994cited by this paper
• Activation of transforming growth factor-β is inhibited in transgenic apolipoprotein(a) mice

  1994cited by this paper
• Molecular genetics of lipoprotein (a): new pieces to the puzzle.

  1994cited by this paper
• Relation of serum homocysteine and lipoprotein(a) concentrations to atherosclerotic disease in a prospective Finnish population based study.

  1994cited by this paper
• Euglobulin clot lysis induced by tissue type plasminogen activator in subjects with increased levels and different isoforms of lipoprotein (a).

  1993cited by this paper
• Lipoprotein (a): A risk factor for peripheral vascular disease

  1993cited by this paper
• Effect of thyroid function on concentrations of lipoprotein(a)

  1993cited by this paper
• Apolipoprotein(a) gene accounts for greater than 90% of the variation in plasma lipoprotein(a) concentrations.

  1992cited by this paper
• Hospital admission and start of benzodiazepine use: Author's reply

  1992cited by this paper
• Lipoprotein(a) and the acute phase response.

  1992cited by this paper
• Effects of the apolipoprotein(a) size polymorphism on the lipoprotein(a) concentration in 7 ethnic groups

  1991cited by this paper
• The effect of n-3 polyunsaturated fatty acids on Lp(a).

  1991cited by this paper
• A palm oil-enriched diet lowers serum lipoprotein(a) in normocholesterolemic volunteers.

  1991cited by this paper
• Quantification of apo[a] and apoB in human atherosclerotic lesions.

  1991influential reference
• Increased serum levels of lipoprotein(a) in diabetes mellitus and their reduction with glycemic control.

  1990cited by this paper
• Atherosclerosis and Cardiovascular Disease

  1990cited by this paper
• Elevated apolipoprotein(A) levels in cancer patients

  1989cited by this paper
• Detection and quantification of lipoprotein(a) in the arterial wall of 107 coronary bypass patients.

  1989cited by this paper
• cDNA sequence of human apolipoprotein(a) is homologous to plasminogen

  1987cited by this paper
• Lipoprotein(a) in ischemic cerebrovascular disease: a new approach to the assessment of risk for stroke.

  1987cited by this paper
• Lp(a) lipoprotein as a risk factor for coronary heart disease and cerebral infarction.

  1986cited by this paper
• The epidemiology of stroke.

  1979cited by this paper

• Гендерные и возрастные особенности концентрации в крови глюкозы и общего холестерина как факторы риска заболеваний сердечно-сосудистой системы по результатам диспансеризации

  2016cites this paper
• Lipoprotein (a) as a risk factor for ischemic stroke: a meta-analysis.

  2015cites this paper